SARS, MERS, COVID-19: Repurposing Drugs for a Pan-Coronavirus Treatment Medical Countermeasures October 15, 2020 …
U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva Industry News October 15, 2020 …
DoD Expands U.S. Domestic Diagnostics Capacity with $481M Cue Health Deal Biodetection October 15, 2020 …
Dublin-Boston Scoring System Helps Predict Which COVID-19 Patients Will Develop Severe Infection Infectious Diseases October 14, 2020 …
UArizona Researchers Publish Latest on SARS-COV-2 Lasting Immunity Antibody Testing Project Biosurveillance October 13, 2020 …
High Dose Favipiravir Countered SARS-CoV-2 in Hamsters, Hydroxychloroquine Ineffective Medical Countermeasures October 10, 2020 …
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV Biodetection October 8, 2020 …
Scientists Publish First In-Depth Look at How CD4+ T Cells Fight SARS-CoV-2 Outbreak News October 8, 2020 …
New Study Shows Coronavirus Antibodies Last at Least Three Months After Infection Outbreak News October 8, 2020 …
Pipeline COVID-19 Vaccines Not Affected by ‘G-Strain’ Mutation Medical Countermeasures October 8, 2020 …
The Challenges of Vaccine Cold-Chain Distribution Must Be Met to End the Pandemic Medical Countermeasures October 5, 2020 …
Vaxxas Awarded $22M to Advance Needle-Free Vaccine Technology for Pandemic Response Industry News October 5, 2020 …
